Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only GSMS Incorporated
Published May 29, 2019 · Recall initiated: May 1, 2019
Summary
FDA records drug Class II recall D-1282-2019, published May 29, 2019 and initiated May 1, 2019. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 11,668 HDPE bottles; Lot: GS017981 exp 02/2020, GS016958 exp 02/2020, GS017341 exp 02/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- IL, MI, MN, PA, TN, TX. Two (2) US government and one (1) Veterans Affairs accounts. No foreign accounts.
- Lot
- GS017981 exp 02/2020, GS016958 exp 02/2020, GS017341 exp 02/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CASeptember 9, 2026
- FDACarbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottlesAugust 26, 2026
- FDAGSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured byJune 17, 2026
- FDAPrimidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by:May 27, 2026
- FDALosartan Potassium Tablets USP 100 mg 90 film coated tablets Manufactured by: Vivimed Life Sciences PrivateMay 29, 2019
- FDATechnopath Multichem S Plus Level 2 - Product Usage: Multichem S Plus (Assayed) is intended for use as anMay 22, 2019
Questions about this recall
Was Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only GSMS Incorporated recalled?
Yes. FDA published recall D-1282-2019 on May 29, 2019. Reported hazard: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit